Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Loss of Tumor Suppressor Gene Functions

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

E-cadherin loss in Cd44-positive gastric cells initiates diffuse gastric cancer in a murine model.

Gut·2026

Same author

Blending space and time to talk about cancer in extended reality.

NPJ digital medicine·2024

Same author

Analytical Validation of Cxbladder<sup>®</sup> Detect, Triage, and Monitor: Assays for Detection and Management of Urothelial Carcinoma.

Diagnostics (Basel, Switzerland)·2024

Same author

E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.

Cancers·2022

Same author

Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking.

Cancers·2022

Same author

E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors.

Cancers·2022

Search research articles

Related Experiment Video

Updated: Jan 13, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

The Changing Landscape of Hereditary Diffuse Gastric Cancer.

Conor Vaessen¹, Kieran Redpath¹, Emily Schulpen¹

¹Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand.

Journal of Gastric Cancer

|January 10, 2026

Summary

Hereditary diffuse gastric cancer (HDGC) is caused by CDH1 or CTNNA1 gene mutations. Early gastric signet ring cell carcinomas develop, which can become invasive, requiring surveillance and gastrectomy for management.

Keywords:

Cadherins Catenins Gastrectomy Neoplastic syndromes Signet ring cell carcinoma

More Related Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

Related Experiment Videos

Last Updated: Jan 13, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

Area of Science:

Oncology
Genetics
Cell Biology

Background:

Hereditary diffuse gastric cancer (HDGC) is an inherited syndrome linked to CDH1 and CTNNA1 gene mutations.
These genes encode E-cadherin and α-catenin, crucial for cell adhesion and epithelial integrity.
Mutations lead to early-onset diffuse gastric cancer and lobular breast cancer.

Purpose of the Study:

To review hereditary diffuse gastric cancer (HDGC) predisposing variants.
To elucidate the mechanisms of diffuse gastric cancer (DGC) initiation and progression.
To outline current diagnostic and management strategies for HDGC.

Main Methods:

Literature review of hereditary diffuse gastric cancer (HDGC) studies.
Analysis of genetic variants in CDH1 and CTNNA1.
Review of current clinical management protocols.

Main Results:

Germline mutations in CDH1 and CTNNA1 are the primary cause of HDGC.
Inactivation of wildtype alleles initiates intramucosal gastric signet ring cell carcinomas (SRCCs).
E-cadherin loss impacts cell adhesion and spindle orientation, potentially driving tumorigenesis.

Conclusions:

HDGC management involves endoscopic surveillance and prophylactic gastrectomy.
Understanding HDGC genetics and mechanisms is key for improved diagnosis and treatment.
Emerging research focuses on HDGC characterization, classification, and novel management approaches.